Mirae Asset Sharekhan

DOWNLOAD SHAREKHAN APP

Mirae Asset Sharekhan

OPEN DEMAT ACCOUNT

LOGIN / TRADE OPEN ACCOUNT

Follow Us :

Sharekhan

BUY NOW Buy Mercury Laboratories Ltd Stock

Open Free Demat and Trading account in 15 minutes

Overview
Market Data
Market Depth
Option Chain
News
Fundamental
Shareholding Pattern
Corporate Action
Peers
Company Info
FAQ’s

Home Stock Mercury Laboratories Ltd

Fri 30/05/2025,16:1:0

NSE

BSE

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 823.05

Previous Close

₹ 831.10

Volume

21

Mkt Cap ( Rs. Cr)

₹98.11

High

₹ 830.00

Low

₹ 817.60

52 Week High

₹ 1190.00

52 Week Low

₹ 736.00

Book Value Per Share

₹ 446.41

Dividend Yield

0.42

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Mercury Laboratories Ltd

Your Vote -

Buy

33.33%

Hold

33.33%

Sell

33.33%

33.33%

3 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Mercury Laboratories Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

Mercury Laboratories - Intimation To Shareholders Relating To Transfer Of Equity Shares To IEPF Authority

20 May 2025, 3:08PM A copy of intimation to shareholders relating to transfer of equity shares to IEPF is attached
Mercury Laboratories - Book Closure & Record Date - Pursuant To Regulation 42 & 30 Of The SEBI (LODR) Regulations, 2015

14 May 2025, 5:47PM Intimation of book closure for the purpose of AGM and final Dividend, if declared s attached
Mercury Laboratories - Intimation For Appointment Of An Internal Auditors, Secretarial Auditors & Cost Auditors

14 May 2025, 4:27PM Intimation for appointment of an internal, secretarial & Cost auditors is attached
Mercury Laboratories - Intimation Of Book Closure

14 May 2025, 3:09PM The Board has approved the app of Mr. Sanjay Patel, as an Independent director, Re app of Mr. Rajendra R Shah as a MD and cessation of Mr. Bharat Meht
Mercury Laboratories - Intimation Of Book Closure

14 May 2025, 3:03PM The Board has approved the appointment of Mr. Sanjay Patel as an Independent director, re-app of MR. Rajendra R Shah and approved cessation of Mr Bhar
Mercury Laboratories Q4 net profit down 41.88% at Rs 1.11 cr

14 May 2025, 2:50PM The company reported standalone net profit of Rs 1.11 crore for the quarter ended March 31, 2025 as compared to Rs 1.91 crore in the same period last
Mercury Laboratories - Corporate Action-Board approves Dividend

14 May 2025, 2:47PM The Board has recommends final dividend or Rs. 3.5 per equity shares for the FY 2024-25, subject to approval of members
Mercury Laboratories - Results For The Financial Year Ended On March 31, 2025

14 May 2025, 2:43PM Result for the financial year ended on March 31, 2025 is attached
Mercury Laboratories - Board Meeting Outcome for Outcome Of Board Meeting Held On May 14, 2025

14 May 2025, 2:34PM Outcome of Board Meeting Held On May 14, 2025 is attached
Mercury Laboratories - Revised Board Meeting Intimation For Approval Of Audited Financial Results For The Quarter And Financi

8 May 2025, 12:36PM In the attached Revised Board Meeting intimation, corrected item no 3 of an appointment of Secretarial Auditor.
Mercury Laboratories - Board Meeting Intimation for Approval Of Audited Financial Results For The Quarter And Financial Year

8 May 2025, 10:54AM Mercury Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2025 ,inter alia, to consider
Mercury Laboratories - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2

29 Apr 2025, 7:20PM <b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border='1px'> <tr> <td><b>Sr
Mercury Laboratories - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

29 Apr 2025, 7:10PM <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border='1px'><tr> <td><b>Sr. No.</b></td
Mercury Laboratories has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

16 Apr 2025, 7:41PM As of March 2025, 73.66% is owned by Indian Promoters and 26.34% by Public. <p align=justify> Top five Promoters holding highest number of shares of M
Mercury Laboratories - Announcement under Regulation 30 (LODR)-Change in Management

16 Apr 2025, 6:23PM Intimation about the resignation of Head of department-Injection is attached
Mercury Laboratories - Disclosure Under Regulation 30 Of The SEBI (LODR) Reg, 2015- Imposition Of Penalty

16 Apr 2025, 6:19PM Disclosure under Reg 30- intimation for Imposition of penalty is attached here
Mercury Laboratories - Change In Email Address Of RTA MUFG Intime India Pvt Ltd

11 Apr 2025, 6:24PM Intimation about the change in email address of RTA is attached
Mercury Laboratories - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

5 Apr 2025, 12:04PM Certificate under Reg 74(5) SEBI (DP) Regulation for the quarter ended on March 31, 2025 is attached

Key fundamentals

Evaluate the intrinsic value of Mercury Laboratories Ltd stock

Name	March-25	March-24	March-23	March-22	March-21
Assets	57.6628	56.3341	50.9931	45.4082	43.1344
Liabilities	57.6628	56.3341	50.9931	45.4082	43.1344
Equity	1.2	1.2	1.2	1.2	1.2
Gross Profit	7.0165	9.0303	8.5705	7.1145	9.5907
Net Profit	3.1449	5.6542	5.5788	3.6862	5.3374
Cash From Operating Activities	4.0011	8.225	2.4524	5.1505	8.2138
NPM(%)	4.18	7.48	7.4	6.36	7.78
Revenue	75.1012	75.559	75.3337	57.9238	68.6014
Expenses	68.0847	66.5287	66.7632	50.8093	59.0107
ROE(%)	5.87	10.55	10.41	6.88	9.96

Shareholding Pattern

Corporate Action

XD-Date	Dividend-Amount	Dividend-%	Dividend Yield(%GE)	Price on that day

From Year	To Year	Class of Share	Authorized Capital(Crores)	Issued Capital(Crores)	Paid Up Shares(NOS)	Paid Up Face Value	Paid Up Capital(Crores)
2023	2024	Equity Share	1.20	1.20	1200000.00	10	1.20
2022	2023	Equity Share	1.20	1.20	1200000.00	10	1.20
2021	2022	Equity Share	1.20	1.20	1200000.00	10	1.20
2020	2021	Equity Share	1.20	1.20	1200000.00	10	1.20
2019	2020	Equity Share	2.50	1.20	1200000.00	10	1.20
2018	2019	Equity Share	2.50	1.20	1200000.00	10	1.20
2017	2018	Equity Share	2.50	1.20	1200000.00	10	1.20
2016	2017	Equity Share	1.20	1.20	1200000.00	10	1.20
2015	2016	Equity Share	1.20	1.20	1200000.00	10	1.20
2014	2015	Equity Share	1.20	1.20	1200000.00	10	1.20
2013	2014	Equity Share	2.00	1.20	1200000.00	10	1.20
2012	2013	Equity Share	2.00	1.20	1200000.00	10	1.20
2011	2012	Equity Share	2.00	1.20	1200000.00	10	1.20
2010	2011	Equity Share	2.00	1.20	1200000.00	10	1.20
2006	2007	Equity Share	2.00	1.20	1200000.00	10	1.20
2005	2006	Equity Share	2.00	1.20	1200000.00	10	1.20
2004	2005	Equity Share	2.00	1.20	1200000.00	10	1.20
1993	1994	Equity Share	2.00	1.20	1200000.00	10	1.20
1992	1993	Equity Share	2.00	0.80	800000.00	10	0.80

Announcement Date	Price	Bonus Ratio	Record Date

Fund	Market Value(CR)	% Hold
No Records Found

Peers

Other companies within the same industry or sector that are comparable to Mercury Laboratories Ltd

Company	Price	Price (% change)	pe(x)	EV/EBITDA(x)	ROE(%)	ROCE(%)
Albert David Ltd	803.05	-0.45	26.62	466.96	301.39	0.62
Lotus Eye Hospital and Institute Ltd	72.28	0.33	205.43	1701.55	3.55	0.00
Bharat Immunological and Biologicals Corporation Ltd	25.50	-1.01	0.00	3532.99	-39.50	0.00
Astec Lifesciences Ltd	671.00	-0.89	0.00	1604.42	-687.10	0.00

Company Info

The Company was incorporated on 12.02.1982, under the name and style of Mercury Laboratories Pvt. Limited. The promoters of the Company were MR. Kantilal Bapulal Shah & Mr. Ramanlal Bapulal Shah. The objective of the company is to manufacture all types of pharmaceutical formulations in the form of tablets, capsules, liquid orals, Injectables and Ointments. The Company became a Public Ltd. company on 15th May 1992 and its name was then changed to Mercury Laboratories Limited. 2015 -Mercury Laboratories is been listed in BSE.

The Company was incorporated on 12.02.1982, under the name and style of Mercury Laboratories Pvt. Limited. The promoters of the Company were MR. Kantilal Bapulal Shah & Mr. Ramanlal Bapulal Shah. The objective of the company is to manufacture all types of pharmaceutical formulations in the form of tablets, capsules, liquid orals, Injectables and Ointments. The Company became a Public Ltd. company on 15th May 1992 and its name was then changed to Mercury Laboratories Limited. 2015 -Mercury Laboratories is been listed in BSE.

Read More

Parent Organisation

Mercury Laboratories Ltd.

Founded

12/02/1982

Managing Director

Mr.Rajendra R Shah

NSE Symbol

FAQ

The current price of Mercury Laboratories Ltd is ₹ 817.60.

The 52-week high for Mercury Laboratories Ltd is

The market capitalization of Mercury Laboratories Ltd is currently ₹ 98.11. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Mercury Laboratories Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Mercury Laboratories Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Mercury Laboratories Ltd shares.

The CEO of Mercury Laboratories Ltd is Mr.Rajendra R Shah, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT